Acceleron  

Publications

Phase 2 Study of Dalantercept Monotherapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck. American Society of Oncology Annual Meeting; May 30 – June 3, 2014
+ DOWNLOAD PDF